Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.

[1]  C. Vanhove,et al.  Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice. , 2011, Contrast media & molecular imaging.

[2]  S. Muyldermans,et al.  A bispecific nanobody to provide full protection against lethal scorpion envenoming , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  V. Petricevich.  Scorpion Venom and the Inflammatory Response , 2010, Mediators of inflammation.

[4]  S. Muyldermans,et al.  Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. , 2009, The Biochemical journal.

[5]  R. Vieira,et al.  Effects of Tityus serrulatus scorpion venom on lung mechanics and inflammation in mice. , 2009, Toxicon : official journal of the International Society on Toxinology.

[6]  F. Laraba-Djebari,et al.  Combination of two antibody fragments F(ab')(2)/Fab: an alternative for scorpion envenoming treatment. , 2008, International immunopharmacology.

[7]  F. Laraba-Djebari,et al.  Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and inflammatory response. , 2008, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[8]  S. Muyldermans,et al.  VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. , 2008, Molecular immunology.

[9]  Christian Vanhove,et al.  Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT , 2008, Journal of Nuclear Medicine.

[10]  G. Slegers,et al.  Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. , 2007, Nuclear medicine and biology.

[11]  C. Rougeot,et al.  Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy. , 2007, Toxicology and applied pharmacology.

[12]  J. D’hooge,et al.  Doppler myocardial imaging in adult male rats: reference values and reproducibility of velocity and deformation parameters. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[13]  M. Jalali,et al.  In vitro and in vivo studies on some toxic effects of the venom from Hemiscorpious lepturus scorpion. , 2006, Toxicon : official journal of the International Society on Toxinology.

[14]  B. Cornelissen,et al.  In vitro and In vivo Targeting Properties of Iodine-123- or Iodine-131–Labeled Monoclonal Antibody 14C5 in a Non–Small Cell Lung Cancer and Colon Carcinoma Model , 2005, Clinical Cancer Research.

[15]  H. Rochat,et al.  Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom. , 2004, Toxicon : official journal of the International Society on Toxinology.

[16]  Serge Muyldermans,et al.  Efficient cancer therapy with a nanobody-based conjugate. , 2004, Cancer research.

[17]  David E Dostal,et al.  Baseline echocardiographic values for adult male rats. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  A. Carayon,et al.  Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients , 2003, Intensive Care Medicine.

[19]  Sanjiv Sam Gambhir,et al.  AMIDE: a free software tool for multimodality medical image analysis. , 2003, Molecular imaging.

[20]  A. R. Meki,et al.  Significance of assessment of serum cardiac troponin I and interleukin-8 in scorpion envenomed children. , 2003, Toxicon : official journal of the International Society on Toxinology.

[21]  T. Quinn,et al.  In vivo evaluation of 188Re‐labeled alpha‐melanocyte stimulating hormone peptide analogs for melanoma therapy , 2002, International journal of cancer.

[22]  D. Dávila,et al.  Sympathetic nervous system activation, antivenin administration and cardiovascular manifestations of scorpion envenomation. , 2002, Toxicon : official journal of the International Society on Toxinology.

[23]  S. E. Hering,et al.  Cardiac troponin I release after severe scorpion envenoming by Tityus serrulatus. , 2002, Toxicon : official journal of the International Society on Toxinology.

[24]  Serge Muyldermans,et al.  Efficient tumor targeting by single‐domain antibody fragments of camels , 2002, International journal of cancer.

[25]  M. Brechbiel,et al.  Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). , 2002, Cancer research.

[26]  F. Van de Werf,et al.  Noninvasive Quantification of the Contractile Reserve of Stunned Myocardium by Ultrasonic Strain Rate and Strain , 2001, Circulation.

[27]  M. El Ayeb,et al.  Evaluation of antivenom therapy in children severely envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpions. , 1999, Toxicon : official journal of the International Society on Toxinology.

[28]  F. Abroug,et al.  Serotherapy in scorpion envenomation: a randomised controlled trial , 1999, The Lancet.

[29]  G W Beresford,et al.  Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  M. Delepierre,et al.  Scorpion toxins specific for Na+-channels. , 1999, European journal of biochemistry.

[31]  L. Possani,et al.  Pharmacokinetics of the toxic fraction of Centruroides limpidus limpidus venom in experimentally envenomed rabbits and effects of immunotherapy with specific F(ab')2. , 1999, Toxicon : official journal of the International Society on Toxinology.

[32]  M. Teixeira,et al.  Pharmacological evidence that neuropeptides mediate part of the actions of scorpion venom on the guinea pig ileum. , 1999, European journal of pharmacology.

[33]  M. Ismail,et al.  Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use. , 1998, Toxicon : official journal of the International Society on Toxinology.

[34]  A. Tarasiuk,et al.  Effects of antivenom serotherapy on hemodynamic pathophysiology in dogs injected with L. quinquestriatus scorpion venom. , 1998, Toxicon : official journal of the International Society on Toxinology.

[35]  S. Sampaio,et al.  Biochemical and histopathological alterations induced in rats by Tityus serrulatus scorpion venom and its major neurotoxin tityustoxin-I. , 1997, Toxicon : official journal of the International Society on Toxinology.

[36]  R. Apte,et al.  Interleukin-6 release following scorpion sting in children. , 1996, Toxicon : official journal of the International Society on Toxinology.

[37]  M. Ismail.  The scorpion envenoming syndrome. , 1995, Toxicon : official journal of the International Society on Toxinology.

[38]  M. Ismail.  The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy. , 1994, Toxicon : official journal of the International Society on Toxinology.

[39]  L L Houston,et al.  Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. , 1993, Cancer research.

[40]  I. M. de Matos,et al.  Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. , 1993, Toxicon : official journal of the International Society on Toxinology.

[41]  C. Rochat,et al.  Purification of animal neurotoxins. Isolation and characterization of eleven neurotoxins from the venoms of the scorpions Androctonus australis hector, Buthus occitanus tunetanus and Leiurus quinquestriatus quinquestriatus. , 1970, European journal of biochemistry.

[42]  N. Lago,et al.  A new venomous scorpion responsible for severe envenomation in Argentina: Tityus confluens. , 2009, Toxicon : official journal of the International Society on Toxinology.

[43]  E. Donadi,et al.  Increased plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-α in patients moderately or severely envenomed by Tityus serrulatus scorpion sting , 2003 .

[44]  H. Daisley,et al.  Acute myocarditis following Tityus trinitatis envenoming: morphological and pathophysiological characteristics. , 1999, Toxicon : official journal of the International Society on Toxinology.

[45]  S. E. Hering,et al.  Severe scorpion envenomation in Brazil. Clinical, laboratory and anatomopathological aspects. , 1994, Revista do Instituto de Medicina Tropical de Sao Paulo.

[46]  S. Sofer,et al.  The cardiovascular system after scorpion envenomation. A review. , 1992, Journal of toxicology. Clinical toxicology.

[47]  L. Freire-Maia.  Pharmacology of Tityus serrulatus scorpion venom. , 1990 .

[48]  S. Sofer,et al.  Respiratory failure in children following envenomation by the scorpion Leiurus quinquestriatus: hemodynamic and neurological aspects. , 1988, Toxicon : official journal of the International Society on Toxinology.

[49]  M. Ismail,et al.  Are the toxicological effects of scorpion envenomation related to tissue venom concentration? , 1988, Toxicon : official journal of the International Society on Toxinology.